Martha G. Sensel

Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy

James B. Nachman, Harland N. Sather, Martha G. Sensel et al. · New England Journal of Medicine · 1998 · 446 citations · Full text

Hematological Malignancy, Intensive Therapy, Post-induction Therapy +15

Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group

Jorge A. Ortega, Edwin C. Douglass, James H. Feusner et al. · Journal of Clinical Oncology · 2000 · 339 citations

Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.

Nyla A. Heerema, James B. Nachman, Harland N. Sather et al. · PubMed · 1999 · 211 citations

Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia

Lei Sun, Nyla A. Heerema, Lisa Crotty et al. · Proceedings of the National Academy of Sciences · 1999 · 197 citations

Treatment Outcome and Prognostic Factors for Infants With Acute Lymphoblastic Leukemia Treated on Two Consecutive Trials of the Children's Cancer Group

Gregory H. Reaman, Richard Sposto, Martha G. Sensel et al. · Journal of Clinical Oncology · 1999 · 184 citations